Please assess the completion status of the following clinical trial:

Trial Title: Exercise in Pediatric Autologous Stem Cell Transplant Patients

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: None
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* autologous SCT at Alberta Children's Hospital (ACH) for malignancy~* age 5 to 18 years of age~* will be receiving myeloablative conditioning regimen~* no evidence of cardiac or pulmonary failure associated with treatment (SF≥28%, EF ≥ 50%)~* no functional nor cognitive limitation that would prohibit performance of the home-based training~* approval by treating oncologist for participants~* a parent or legal guardian must sign the consent form and~* children should express verbal assent to participate.~Exclusion Criteria:~-

- Gender: ALL
- Minimum Age: 5 Years
- Maximum Age: 18 Years
- Healthy Volunteers: f

Study Arms:
- Exercise (EX) (Type: EXPERIMENTAL): This group will perform two phases of an EX program.
- Standard Care (Type: ACTIVE_COMPARATOR): This group will follow the standard care without any EX prescription.

Based on this trial design, predict the completion outcome and termination type (if applicable).